F. Vega, M. Múgica, R. Bazire, L. Argiz, M. Belver, A. Friera, C. Blanco
{"title":"碘造影剂的不良反应:一项研究方案的安全性,包括寻找替代造影剂的快速全剂量肠外激发试验","authors":"F. Vega, M. Múgica, R. Bazire, L. Argiz, M. Belver, A. Friera, C. Blanco","doi":"10.1111/cea.13518","DOIUrl":null,"url":null,"abstract":"Iodinated contrast media (ICM) were introduced into clinical practice to improve both diagnostic imaging and therapeutic procedures. Current ICM formulations are based on tri-iodobenzoic acid ring. Incidence of adverse reactions (AR) to ICM was 15% in 1975, but nowadays it has been reduced to 3% by using low-osmolarity and non-ionic ICM.","PeriodicalId":10148,"journal":{"name":"Clinical & Experimental Allergy","volume":"21 1","pages":"271 - 274"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Adverse reactions to iodinated contrast media: Safety of a study protocol that includes fast full‐dose parenteral challenge tests searching for an alternative contrast media\",\"authors\":\"F. Vega, M. Múgica, R. Bazire, L. Argiz, M. Belver, A. Friera, C. Blanco\",\"doi\":\"10.1111/cea.13518\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Iodinated contrast media (ICM) were introduced into clinical practice to improve both diagnostic imaging and therapeutic procedures. Current ICM formulations are based on tri-iodobenzoic acid ring. Incidence of adverse reactions (AR) to ICM was 15% in 1975, but nowadays it has been reduced to 3% by using low-osmolarity and non-ionic ICM.\",\"PeriodicalId\":10148,\"journal\":{\"name\":\"Clinical & Experimental Allergy\",\"volume\":\"21 1\",\"pages\":\"271 - 274\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical & Experimental Allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/cea.13518\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Experimental Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/cea.13518","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Adverse reactions to iodinated contrast media: Safety of a study protocol that includes fast full‐dose parenteral challenge tests searching for an alternative contrast media
Iodinated contrast media (ICM) were introduced into clinical practice to improve both diagnostic imaging and therapeutic procedures. Current ICM formulations are based on tri-iodobenzoic acid ring. Incidence of adverse reactions (AR) to ICM was 15% in 1975, but nowadays it has been reduced to 3% by using low-osmolarity and non-ionic ICM.